See the DrugPatentWatch profile for Ranitidine
Ranitidine syrup was prescribed for pediatric use to treat and prevent various gastrointestinal conditions. These included peptic ulcers, Zollinger-Ellison syndrome, and gastroesophageal reflux disease (GERD) [1][2]. It was also used to treat erosive esophagitis and to manage conditions where excessive stomach acid production was a concern [1].
What happened to ranitidine syrup?
Ranitidine products, including syrups, were voluntarily recalled and subsequently discontinued from the market in the United States and other countries due to the detection of N-nitrosodimethylamine (NDMA), a probable human carcinogen [3][4]. This issue led to regulatory actions by agencies like the U.S. Food and Drug Administration (FDA) [3].
Are there alternatives to ranitidine syrup for children?
Yes, several alternative medications are available for pediatric gastrointestinal issues. These include other H2 blockers and proton pump inhibitors (PPIs) that have demonstrated safety and efficacy in children [5][6]. Specific alternatives depend on the condition being treated and the child's age and weight [5].
How do H2 blockers work for pediatric GERD?
H2 blockers, like ranitidine previously did, work by reducing the amount of acid produced by the stomach [1]. They target histamine-2 receptors on the cells that make stomach acid, thereby decreasing acid secretion. This reduction in acid can help alleviate symptoms of GERD and promote healing of esophageal inflammation in children [1][5].
When did ranitidine get taken off the market?
Following initial recalls in September 2019, the FDA requested a market withdrawal of all prescription and over-the-counter ranitidine products in April 2020 due to unacceptable levels of NDMA [3][4].
What are the risks associated with ranitidine?
The primary concern leading to ranitidine's discontinuation was the presence of NDMA, a substance classified as a probable human carcinogen [3][4]. While the immediate risks to individuals were considered low at the time of the recalls, the long-term implications and the potential for NDMA to form over time in the medication were the driving factors for its removal from the market [3].
What is the difference between ranitidine and famotidine?
Both ranitidine and famotidine are H2 blockers used to reduce stomach acid [1][5]. Famotidine has remained available and is now a primary alternative for conditions previously treated with ranitidine [5][6]. While they work on the same mechanism, they are different chemical compounds, and famotidine has not been associated with the same NDMA contamination issues that led to ranitidine's withdrawal [3][5].
What other stomach acid reducers are used for children?
Besides famotidine, other medications used to reduce stomach acid in children include other H2 blockers and proton pump inhibitors (PPIs) such as omeprazole, lansoprazole, and esomeprazole [5][6]. The choice of medication depends on the specific diagnosis and the patient's medical history [5].
What is Zollinger-Ellison syndrome in children?
Zollinger-Ellison syndrome is a rare condition characterized by the development of one or more tumors (gastrinomas) that produce excessive amounts of gastrin [1][7]. This leads to hypersecretion of stomach acid, causing severe peptic ulcers and other gastrointestinal problems [1]. Ranitidine was used to manage the excess acid production associated with this syndrome in pediatric patients [1].
What is gastroesophageal reflux disease (GERD) in children?
GERD in children occurs when stomach acid frequently flows back into the esophagus, the tube connecting the mouth and stomach [2]. This can cause symptoms like heartburn, regurgitation, vomiting, and poor weight gain in infants, or more severe issues like esophagitis and respiratory problems in older children [2]. Treatment aims to reduce stomach acid and improve the function of the lower esophageal sphincter [1][5].
Sources:
[1] https://www.drugpatentwatch.com/
[2] https://www.aboutkidshealth.ca/article/gastroesophageal-reflux-ger
[3] https://www.fda.gov/drugs/drug-recalls/FDA-request-all-manufacturers-withdraw-all-prescription-and-over-counter-ranitidine-products-drug-store
[4] https://www.drugpatentwatch.com/blog/ranitidine-recall-explained
[5] https://www.chop.edu/conditions-diseases/gastroesophageal-reflux-disease-gerd
[6] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4919074/
[7] https://www.mayoclinic.org/diseases-conditions/zollinger-ellison-syndrome/symptoms-causes/syc-20373895